BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27551257)

  • 1. Multifaceted Role of Sialylation in Prion Diseases.
    Baskakov IV; Katorcha E
    Front Neurosci; 2016; 10():358. PubMed ID: 27551257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sialylation in prion disease pathogenesis and prion structure.
    Baskakov IV
    Prog Mol Biol Transl Sci; 2020; 175():31-52. PubMed ID: 32958238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sialylation of N-linked glycans in prion pathogenesis.
    Makarava N; Baskakov IV
    Cell Tissue Res; 2023 Apr; 392(1):201-214. PubMed ID: 35088180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialylation Controls Prion Fate
    Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
    J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
    Katorcha E; Makarava N; Savtchenko R; Baskakov IV
    Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in ST6GAL1, one of the two α2,6-sialyltransferases, has only a minor effect on the pathogenesis of prion disease.
    Makarava N; Katorcha E; Chang JC; Lau JTY; Baskakov IV
    Front Mol Biosci; 2022; 9():1058602. PubMed ID: 36452458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of N-linked glycans of PrP
    Katorcha E; Baskakov IV
    FEBS J; 2017 Nov; 284(21):3727-3738. PubMed ID: 28898525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation.
    Katorcha E; Daus ML; Gonzalez-Montalban N; Makarava N; Lasch P; Beekes M; Baskakov IV
    Sci Rep; 2016 Sep; 6():33119. PubMed ID: 27609323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
    Makarava N; Chang JC; Baskakov IV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.
    Katorcha E; Srivastava S; Klimova N; Baskakov IV
    J Biol Chem; 2016 Aug; 291(33):17009-19. PubMed ID: 27317661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited understanding of the functional diversity of N-linked glycans as a major gap of prion biology.
    Baskakov IV
    Prion; 2017 Mar; 11(2):82-88. PubMed ID: 28324664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion Strain-Specific Structure and Pathology: A View from the Perspective of Glycobiology.
    Baskakov IV; Katorcha E; Makarava N
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30567302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple steps of prion strain adaptation to a new host.
    Bocharova O; Makarava N; Pandit NP; Molesworth K; Baskakov IV
    Front Neurosci; 2024; 18():1329010. PubMed ID: 38362022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple steps of prion strain adaptation to a new host.
    Bocharova O; Makarava N; Pandit NP; Molesworth K; Baskakov IV
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier.
    Igel A; Fornara B; Rezaei H; Béringue V
    Cell Tissue Res; 2023 Apr; 392(1):149-166. PubMed ID: 36399162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two alternative pathways for generating transmissible prion disease de novo.
    Makarava N; Savtchenko R; Baskakov IV
    Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory response of microglia to prions is controlled by sialylation of PrP
    Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
    Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.
    Cescatti M; Saverioni D; Capellari S; Tagliavini F; Kitamoto T; Ironside J; Giese A; Parchi P
    J Virol; 2016 Jul; 90(14):6244-6254. PubMed ID: 27122583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.
    Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V
    Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.